VisCardia Overview

  • Founded
  • 2015

Founded
  • Status
  • Private

  • Employees
  • 4

Employees
  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $1.5M

  • Investors
  • 1

VisCardia General Information

Description

Developer of a privately held medical device designed to treat thoracic cardiac diseases. The company's device is based on an implantable electronic sensor and electrode system that delivers chronic electrical stimulation for mediating thoracic pressure augmentation, enabling patients to use their own thoracic musculature to improve cardiac filling and relieve symptoms resulting from hemodynamic insufficiency.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Therapeutic Devices
Primary Office
  • 8870 South West Nimbus Avenue
  • Beaverton, OR 97008
  • United States
+1 (503) 000-0000

VisCardia Timeline

2019202020212022
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

VisCardia Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC 05-Apr-2022 $1.5M 00.000 Completed Generating Revenue
4. Later Stage VC 13-Apr-2021 00000 00.000 Completed Generating Revenue
3. Early Stage VC 04-Feb-2019 00000 00.000 Completed Generating Revenue
2. Early Stage VC 12-Nov-2017 $750K $2.75M Completed Generating Revenue
1. Early Stage VC (Series B) 01-Feb-2017 $2M $2M Completed Generating Revenue
To view VisCardia’s complete valuation and funding history, request access »

VisCardia Patents

VisCardia Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20210299450-A1 Implantable medical systems, devices and methods for delivering asymptomatic diaphragmatic stimulation Pending 27-Mar-2020 0000000000
US-20210093859-A1 Implantable medical systems, devices, and methods for affecting cardiac function through diaphragm stimulation, and for monitoring diaphragmatic health Pending 26-Sep-2019 0000000000 0
US-20210093856-A1 Implantable medical systems, devices, and methods for affecting cardiac function through diaphragm stimulation, and for monitoring diaphragmatic health Pending 26-Sep-2019 0000000000
EP-4034223-A1 Implantable medical systems, devices, and methods for affecting cardiac function through diaphragm stimulation, and for monitoring diaphragmatic health Pending 26-Sep-2019 0000000000
US-20210093857-A1 Implantable medical systems, devices, and methods for affecting cardiac function through diaphragm stimulation, and for monitoring diaphragmatic health Pending 26-Sep-2019 A61N1/3601
To view VisCardia’s complete patent history, request access »

VisCardia Executive Team (2)

Name Title Board Seat Contact Info
Peter Bauer Ph.D President & Chief Executive Officer
You’re viewing 1 of 2 executive team members. Get the full list »

VisCardia Board Members (3)

Name Representing Role Since
David Chazanovitz Self Chairman 000 0000
M. Ross Kinetic Capital Partners Board Member 000 0000
You’re viewing 2 of 3 board members. Get the full list »

VisCardia Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

VisCardia Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Kinetic Capital Partners PE/Buyout Minority 000 0000 000000 0
To view VisCardia’s complete investors history, request access »